Clinical Trials Browser

Phase 3 × INDUSTRY × orteronel × Clear all

NCT01193257 2018-12-19

Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.

Phase 3 Completed

1,099 enrolled 32 charts

Prostatic Neoplasms

NCT01193244 2017-05-17

Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

Phase 3 Completed

1,560 enrolled 35 charts

Prostatic Neoplasms